The three-drug combination of Tagrisso plus platinum-based chemotherapy and pemetrexed boosted outcomes for patients with EGFR-mutant advanced non-small cell lung cancer. Tagrisso(osimertinib) ...
LONDON, Aug 6 (Reuters) - Britain's healthcare cost-effectiveness watchdog has changed its mind on Eli Lilly's drug Alimta and now plans to recommend its use within the state health service as a ...
(Recasts, adds study details, doctor comment, background) By Maggie Fox, Health and Science Editor WASHINGTON, May 15 (Reuters) - Adding a little extra chemotherapy after finishing the initial course ...
Influence on the Health of the Partner Affected by Tumor Disease in the Wife or Husband Based on a Population-Based Register Study of Cancer in Sweden Pemetrexed-carboplatin is inferior for the ...
A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B ...
lung cancer Pemrydi RTU is expected to be available in the first quarter of 2024. The Food and Drug Administration (FDA) has approved Pemrydi RTU ® (pemetrexed injection), a ready-to-use (RTU) ...
July 7 -- MONDAY, July 6 (HealthDay News) -- The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic ...
LONDON (MarketWatch) -- The U.K. National Institute for Health and Clinical Excellence, or NICE, Wednesday said Eli Lilly & Co's LLY lung cancer drug Alimta should be reimbursed for the treatment of ...
Dr. Deborah Doroshow presents Sandra, a 54-year-old never-smoker diagnosed 14 months ago with stage IVA non-small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results